Allergan Steers Bimatoprost Eyelash Enhancer To Drug, Not Cosmetic, Market

Allergan says it will file a new drug application with FDA later this year for the eyelash growth stimulant bimatoprost, the key ingredient in cosmetic offerings that caught the drug company's - and FDA's - watchful eye earlier this year